Unlock stock picks and a broker-level newsfeed that powers Wall Street.

The 'Double Whammy' That Sent Sarepta Stock To An Eight-Year Low
The 'Double Whammy' That Sent Sarepta Stock To An Eight-Year Low · Investor's Business Daily

In This Article:

Sarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical FDA appointment.